UK-founded women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women’s health.
Juno Bio has raised €3.3M across 1 funding round from 4 investors, most recently a round in Jul 2026. Based in London, UK; active in Healthtech. Data as of 16 Jul 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-16 | Other | €3.3M |
| Ada Ventures,Artesian VC,Entrepreneur First,Illumina Accelerator |
| View deal → |
